Avalon GloboCare Corporation (ALBT): Price-to-Revenue Ratio

Brandmark of Avalon GloboCare Corporation (ALBT)

Avalon GloboCare is developing a biomedical service, increasing profitability through the digitalization of diagnostics. Tracking the P/S time series on GURU.Markets, we note a pivot driven by the implementation of rapid tests and a unique protein modification technology against cancer. The value 3.90 represents the current level of the metric, confirming market expectations for the innovative pipeline and the company's strong pricing power.

ALBT Avalon GloboCare Corporation Price-to-Revenue Ratio (04/28/2023 - 07/22/2026)

Analytical breakdowns for Avalon GloboCare Corp. (ALBT)

- stock value and consensus price forecast:
- stock exchange capitalization data:
Fundamental company analysis:Avalon GloboCare ALBT
Finished products of avalon-globocare.com

The P/S ratio determines the market value of a business relative to its annual sales volume. Current P/S dynamics reflect the ratio of total market capitalization to revenue, allowing for an assessment of the premium investors are paying per unit of income. This metric is highly sensitive to changes in operating flows and market expectations. For Avalon GloboCare (ALBT), such fluctuations are amplified by geopolitical risks that disrupt biomaterial logistics and hinder the development of cell therapy.

Competitors of Avalon GloboCare

HCA (HCA Healthcare) - Market Capitalization-to-Revenue Ratio|Tenet Healthcare Corporation - Market Cap to Revenue|Fresenius Medical (FMS) - Price to Sales|Solventum Corp - P/S Multiple|Price-to-Sales Ratio EHC|Universal Health Services (UHS) - Price-to-Revenue Ratio|DaVita - Market Capitalization-to-Revenue Ratio|Market Cap to Revenue RDNT|OPCH: Market Capitalization-to-Revenue Ratio|Market Cap to Revenue SGRY (Surgery Partners, Inc.)|PINC (Premier, Inc.) - Market Capitalization-to-Revenue Ratio|National Vision - Market Cap to Revenue|Price-to-Revenue Coefficient Progyny Inc (PGNY)|Ardent Health - P/S Multiple|Price-to-Revenue Coefficient Select Medical Corp SEM|ASTH: P/S Multiple|Market Cap to Revenue Ratio MD|USPH (US Physical Therapy Inc) - P/S Multiple|PNTG: Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Organogenesis Corp (ORGO)|NUTX (Nutex Health Corp) - Market Capitalization-to-Revenue Ratio|P/S Multiple AUNA (Auna S.A.)|SBC Medical Group Holdings Inc (SBC) - Price to Sales|EOLS - Price-to-Revenue Ratio|Market Capitalization-to-Revenue Ratio CYH (Community Health Systems Inc)|SKIN (beautyhealth.com) - Market Cap to Revenue|Market Cap to Revenue Ratio MDWD|Price-to-Revenue Ratio biote Corp.|Price to Sales thejoint.com JYNT|P/S Multiple DCGO|Market Cap to Revenue P3 Health PIII|P/S Multiple GANX (Gain Therapeutics Inc.)|P/S Multiple EUDA Health Holdings Limited EUDA|baselmedical.com - P/S Multiple|CLGN: Price-to-Revenue Ratio|Cuprina Holdings (Cayman) Ltd. (CUPR) - Price-to-Revenue Ratio|Market Cap to Revenue Concord Medical|AMS (American Shared Hospital Services Inc) - P/S Multiple|MEDIROM Corp (MRM) - Price-to-Revenue Coefficient|P/S Multiple DHAI|Longevity Health Holdings - Market Cap to Revenue Ratio|Price-to-Revenue Ratio NewGenIvf Group Ltd NIVF|ATIP (atipt.com) - Price-to-Sales Ratio|CMAX: Market Cap to Revenue|Price to Sales Kindly Health|ModivCare (MODV) - Price-to-Revenue Ratio|NVOS (novointegrated.com) - Price-to-Revenue Ratio|SSY (SunLink Health Systems Inc.) - P/S Multiple|BACK (IMAC Holdings Inc) - Market Cap to Sales Volume